PRUEBA PARA LA DETERMINACIÓN DE GLICOHEMOGLOBINA (HBA 1)
Mexico·Clase I·III. Agentes de diagnóstico·DICIPA, S.A. DE C.V.·Registered July 14, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- SET DE REACTIVOS PARA GLICOHEMOGLOBINA POINTE SCIENTIFIC
- Trade Name (English)
- SET DE REACTIVOS PARA GLICOHEMOGLOBINA POINTE SCIENTIFIC
- Analysis ID
- 0599R2022 SSA
- Registration Date
- July 14, 2022
- Name (Spanish)
- DICIPA, S.A. DE C.V.
- Name (English)
- DICIPA, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA PARA LA DETERMINACIÓN DE GLICOHEMOGLOBINA (HBA 1) (PRUEBA PARA LA DETERMINACIÓN DE GLICOHEMOGLOBINA (HBA 1)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0599R2022 SSA and manufactured by DICIPA, S.A. DE C.V.. The device was registered on July 14, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.